Evonik Industries (FRA:EVK) received a €27.00 ($32.14) price objective from equities research analysts at UBS Group in a report issued on Monday, www.boersen-zeitung.de reports. The firm currently has a “sell” rating on the stock. UBS Group’s price objective indicates a potential downside of 16.82% from the stock’s current price.
A number of other analysts have also recently commented on EVK. Credit Suisse Group set a €34.30 ($40.83) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, September 26th. Deutsche Bank set a €32.00 ($38.10) price target on Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, September 28th. Baader Bank set a €38.00 ($45.24) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Thursday, September 28th. Barclays set a €34.50 ($41.07) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Friday, September 29th. Finally, DZ Bank reaffirmed a “neutral” rating on shares of Evonik Industries in a research report on Monday, October 2nd. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the company’s stock. Evonik Industries has a consensus rating of “Hold” and a consensus price target of €33.87 ($40.32).
Shares of Evonik Industries (FRA:EVK) traded up €0.48 ($0.57) on Monday, reaching €32.46 ($38.64). The company’s stock had a trading volume of 1,152 shares. Evonik Industries has a 12 month low of €26.78 ($31.88) and a 12 month high of €32.97 ($39.25). The firm has a market cap of $15,100.00 and a PE ratio of 20.68.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.